Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2567-2578

  Murohara, Toyoaki ^a   Asahara, Takayuki ^a   Silver, Marcy ^a   Bauters, Christophe ^a   Masuda, Haruchika ^a   Kalka, Christoph ^a   Kearney, Marianne ^a   Chen, Donghui ^a   Chen, Dongfen ^a   Symes, James F ^a   Fishman, Mark C ^b   Huang, Paul L ^b   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; eNOS (NOS 3); L arginine; Nitric oxide (NO); Vascular endothelial growth factor (VEGF)

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CAPILLARY DENSITY; DIET SUPPLEMENTATION; DOPPLER FLOWMETRY; DOWN REGULATION; HINDLIMB; ISCHEMIA; LIMB PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 0032102292     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1560     Document Type: Article

References (61)

1. Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:373-376.
2. Schmidt, H.H., and U. Walter. 1994. NO at work. Cell. 78:919-925.
3. Forstermann, U., I.I. Closs, J.S. Pollock, M. Nakane, P. Schwarz, I. Gath, and H. Kleinert. 1994. Nitric oxide synthase isoenzymes: characterization, purification, molecular cloning, and functions. Hypertension. 23:1121-1131.
4. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
5. Ignarro, L.J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535-560.
6. Creager, M.A., S.J. Gallagher, X.J. Girerd, S.M. Coleman, V.J. Dzau, and J.P. Cooke. 1992. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90:1248-1253.
7. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
8. Steudel, W., F. Ichinose, P. Huang, W.E. Hurford, R.C. Jones, J.A. Bevan, M.C. Fishman, and W.M. Zapol. 1997. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS3) gene. Circ. Res. 81:34-41.
9. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138:213-221.
10. Ku, D.D., J.K. Zaleski, S. Liu, and T.A. Brock. 1993. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265:H586-H592.
11. van der Zee, R., T. Murohara, Z. Luo, F. Zollmann, J. Passeri, C. Lekutat, and J.M. Isner. 1997. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 95:1030-1037.
12. Bauters, C., T. Asahara, L.P. Zheng, S. Takeshita, S. Bunting, N. Ferrara, J.F. Symes, and J.M. Isner. 1995. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 91:2802-2809.
13. Horowitz, J.R., A. Rivard, R. van der Zee, M.D. Hariawala, D.D. Sheriff, D.D. Esakof, G.M. Chaudhry, J.F. Symes, and J.M. Isner. 1997. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Arterioscler. Thromb. Vasc. Biol. 17:2793-2800.
14. Isner, J.M. 1998. Angiogenesis. In Textbook of Cardiovascular Medicine. E.J. Topol, editor. Lippincott-Raven Publishers, Philadelphia, PA. 2491-2518.
15. Asahara, T., C. Bauters, C.J. Pastore, M. Kearney, S. Rossow, S. Bunting, N. Ferrara, J.F. Symes, and J.M. Isner. 1995. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 91:2793-2801.
16. 165 gene transfer. Circulation. 94:3291-3302.
17. Papapetropoulos, A., K.M. Desai, R.D. Rudic, B. Mayer, R. Zhang, M.P. Ruiz-Torres, G. Garcia-Cardena, J.A. Madri, and W.C. Sessa. 1997. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-b1-stimulated capillary organization in vitro. Am. J. Pathol. 150:1835-1844.
18. Papapetropoulos, A., G. Garcia-Cardena, J.A. Madri, and W.C. Sessa. 1997. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100: 3131-3139.
19. Ziehe, M., L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, C.A. Maggi, P. Geppetti, and F. Ledda. 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94:2036-2044.
20. Ziehe, M., L. Morbidelli, R. Choudhuri, H.-T. Zhang, S. Donnini, H.J. Granger, and R. Bicknell. 1997. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced hut not fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99:2625-2634.
21. Takeshita, S., L.P. Zheng, E. Brogi, M. Kearney, L.Q. Pu, S. Bunting, N. Ferrara, J.F. Symes, and J.M. Isner. 1994. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revasculariza-tion in a rabbit ischemic hindlimb model. J. Clin. Invest. 93:662-670.
22. Couffinhal, T., M. Silver, M. Kearney, A. Sullivan, and J.M. Isner. 1996. Angiogenesis is impaired in ApoE knock out mice due to reduced expression of vascular endothelial growth factor. Circulation. 94:I-102. (Abstr.)
23. Bauters, C., T. Asahara, L.P. Zheng, S. Takeshita, S. Bunting, N. Ferrara, J.F. Symes, and J.M. Isner. 1994. Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267: H1263-H1271.
24. Baffour, R., J. Berman, J.L. Garb, S.W. Rhee, J. Kaufman, and P. Friedmann. 1992. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 16:181-191.
25. Ziada, A.M., O. Hudlicka, K.R. Tyler, and A.J. Wright. 1984. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc. Res. 18:724-732.
26. Flanagan, M.F., A.M. Fujii, S.D. Colan, R.G. Flanagan, and J.E. Lock. 1991. Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb: evidence for inhibition with chronic protamine administration. Circ. Res. 68:1458-1470.
27. Khan, F., J.J. Palacino, J.D. Coffman, and R.A. Cohen. 1993. Chronic inhibition of nitric oxide production augments skin vasoconstriction in the rabbit ear. J. Cardiovasc. Pharmacol. 22:280-286.
28. Couffinhal, T., M. Silver, L.P. Zheng, M. Kearney, B. Witzenbichler, and J.M. Isner. 1998. A mouse model of angiogenesis. Am. J. Pathol. In press.
29. Namiki, A., E. Brogi, M. Kearney, T. Wu, T. Couffinhal, L. Varticovski, and J.M. Isner. 1995. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:31189-31195.
30. 165. Lancet. 348:370-374.
31. Hariawala, M., J.R. Horowitz, D. Esakof, D.D. Sheriff, D.H. Walter, G.M. Chaudhry, V. Desai, B. Keyt, J.M. Isner, and J.F. Symes. 1996. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J. Surg. Res. 63:77-82.
32. Pearlman, J.D., M.G. Hibberd, M.L. Chuang, K. Harada, J.J. Lopez, S.R. Gladston, M. Friedman, F.W. Sellke, and M. Simons. 1995. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat. Med. 1:1085-1089.
33. Takeshita, S., Y. Tsurumi, T. Couffinhal, T. Asahara, C. Bauters, J.F. Symes, N. Ferrara, and J.M. Isner. 1996. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75:487-502.
34. Keefer, L.K., R.W. Nims, K.M. Davies, and D.A. Wink. 1996. NON-Oates (1-substituted diazen-1-ium-1, 2-diolates). Methods Enzymol. 268:281-293.
35. Liebmann, J., A.M. DeLuca, D. Coffin, L.K. Keefer, D. Venzon, D.A. Wink, and J.B. Mitchell. 1994. In vivo radiation protection by nitric oxide modulation. Cancer Res. 54:3365-3368.
36. Lau, Y.-T., and W.-C. Ma. 1996. Nitric oxide inhibits migration of cultured endothelial cells. Biochem. Biophys. Res. Commun. 221:670-674.
37. Sholley, M.M., G.P. Ferguson, H.R. Seibel, J.L. Montour, and J.D. Wilson. 1984. Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51:624-634.
38. Pipili-Synetos, E., E. Sakkoula, and M.E. Maragoudakis. 1993. Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108:855-857.
39. Pipili-Synetos, E., E. Sakkoula, G. Haralabopoulos, P. Andriopoulou, P. Peristeris, and M.E. Maragoudakis. 1994. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111:894-902.
40. Guo, J.-P., M.M. Panday, P.M. Consigny, and A.M. Lefer. 1995. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am. J. Physiol. 269:H1122-H1131.
41. Morbidelli, L., C.-H. Chang, J.G. Douglas, H.J. Granger, F. Ledda, and M. Ziehe. 1995. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270:H411-H415.
42. Shesely, E.G., N. Maeda, H.-S. Kim, K.M. Desai, J.H. Krege, V.E. Lauhach, P.A. Sherman, W.C. Sessa, and O. Smithies. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 93:13176-13181.
43. Tomanek, R.J., J.C. Searls, and P.A. Lachenbruch. 1982. Quantitative changes in the capillary bed during developing peak and stabilized cardiac hypertrophy in the spontaneously hypertensive rat. Circ. Res. 51:295-304.
44. Anversa, P., A.V. Loud, F. Giacomelli, and J. Weiner. 1978. Absolute morphometric study of myocardial hypertrophy in experimental hypertension. II. Ultrastructure of myocardium and interstitium. Lab. Invest. 38:597-609.
45. Nicosia, R.F., S.V. Nicosia, and M. Smith. 1994. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol. 145:1023-1029.
46. Banai, S., M.T. Jaklitsch, M. Shou, D.F. Lazarous, M. Scheinowitz, S. Biro, S.E. Epstein, and E.F. Unger. 1994. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:2183-2189.
47. Guo, J.-P., T. Murohara, M.M. Panday, and A.M. Lefer. 1996. Nitric oxide promotes endothelial cell proliferation: role in inhibiting restenosis. Circulation. 92:I-750.
48. Arnal, J.F., T. Munzel, R.C. Venema, N.L. James, C.L. Bai, W.E. Mitch, and D.G. Harrison. 1995. Interaction between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J. Clin. Invest. 95:2565-2572.
49. Kubes, P., M. Suzuki, and D.N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte-adhesion. Proc. Natl. Acad. Sci. USA. 88:4651-4655.
50. Ito, A., K. Egashira, T. Kadokami, Y. Fukumoto, T. Takayanagi, R. Nakaike, T. Kuga, K. Sueishi, H. Shimokawa, and A. Takeshita. 1995. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation. 92:2636-2644.
51. Sessa, W.C. 1994. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:131-143.
52. Takemoto, M., K. Egashira, M. Usui, K. Numaguchi, H. Tomita, H. Tsutsui, H. Shimokawa, K. Sueishi, and A. Takeshita. 1997. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J. Clin. Invest. 99:278-287.
53. Tsurumi, Y., T. Murohara, K. Krasinski, C. Dongfen, B. Witzenbichler, M. Kearney, T. Couffinhal, and J.M. Isner. 1997. Reciprocal relationship between VEGF and NO in the regulation of endothelial integrity. Nat. Med. 3: 879-886.
54. Boger, R.H., S.M. Bode-Boger, W. Thiele, W. Junker, K. Alexander, and J.C. Frolich. 1997. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 95:2068-2074.
55. Wang, B.-Y., R.C. Candipan, M. Arjomandi, P.T. Hsium, P.S. Tsao, and J.P. Cooke. 1996. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J. Am. Coll. Cardiol. 28:1573-1579.
56. Chauhan, A., R.S. More, P.A. Mullins, G. Taylor, M.C. Petch, and P.M. Schofield. 1996. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J. Am. Coll. Cardiol. 28:1796-1804.
57. Hamon, M., B. Vallet, C. Bauters, N. Wernert, E.P. McFadden, J.-M. Lablanche, B. Dupuis, and M.E. Bertrand. 1994. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 90:1357-1362.
58. Bode-Boger, S.M., R.H. Boger, H. Alfke, D. Heinzel, D. Tsikas, A. Creutzig, K. Alexander, and J. Frolich. 1996. L-arginine induces nitric-oxide dependent vasodilation in patients with critical limb ischemia. A randomized controlled study. Circulation. 93:85-90.
59. Girerd, X.J., A.T. Hirsch, J.P. Cooke, V.J. Dzau, and M.A. Creager. 1990. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ. Res. 67:1301-1308.
60. Weyrich, A.S., X.-L. Ma, and A.M. Lefer. 1992. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 86:279-288.
61. Giugliano, D., R. Marfella, G. Verrazzo, R. Acampora, L. Coppola, D. Cozzolino, and F. D'Onofrio. 1997. The vascular effects of L-arginine in humans. The role of endogenous insulin. J. Clin. Invest. 99:433-438.